Key statistics
As of last trade Vertex Pharmaceuticals Inc (VX1:STU) traded at 429.20, -12.40% below its 52-week high of 489.95, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 426.35 |
---|---|
High | 429.40 |
Low | 426.35 |
Bid | 429.50 |
Offer | 430.00 |
Previous close | 425.45 |
Average volume | 109.44 |
---|---|
Shares outstanding | 257.53m |
Free float | 257.33m |
P/E (TTM) | -- |
Market cap | 115.98bn USD |
EPS (TTM) | -1.99 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Vertex Reports Third Quarter 2024 Financial Results
- Vertex to Participate in Upcoming November Investor Conferences
- Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
- Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
- Vertex to Announce Third Quarter 2024 Financial Results on November 4th
- Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
More ▼